The retina is one of the most metabolically active, oxygen-hungry tissues in the human body relative to its size — and it's under constant light exposure, which generates oxidative stress as a natural byproduct. This combination makes antioxidant support one of the most consistently studied angles in eye nutrition.
The National Eye Institute's original AREDS formula used vitamin C (500mg), vitamin E (400 IU), beta-carotene (15mg), zinc (80mg), and copper (2mg) — establishing high-dose antioxidant supplementation as a credible intervention for slowing AMD progression in an already-diagnosed population [1]. AREDS2 later replaced beta-carotene with lutein and zeaxanthin due to a lung cancer risk found in smokers taking beta-carotene, with the newer formulation showing modestly better AMD-progression outcomes [1][2].
Astaxanthin has drawn research interest for its ability to cross the blood-retinal barrier, giving it more direct antioxidant access to retinal tissue — see our full astaxanthin guide. Alpha lipoic acid is notable for a different reason: it helps "recycle" other antioxidants like vitamin C and E after they've already neutralized free radicals, extending their functional lifespan rather than acting as a standalone antioxidant itself.
Antioxidant support is one of the better-evidenced categories in eye nutrition specifically because of the AREDS/AREDS2 research lineage — but it's worth remembering that dose matters. A trace amount of vitamin E or beta-carotene in a general multivitamin is a different proposition than the doses actually used in the research. See our guide to reading supplement labels for how to check this.